Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/6/2025

Management of Bilateral Empyema with Staphylococcus warneri Infection

Immediate Antibiotic Therapy

  • The Infectious Diseases Society of America recommends starting IV vancomycin 15-20 mg/kg every 8-12 hours immediately upon diagnosis, targeting staphylococcal coverage 1, 2
  • Adjust antibiotics based on culture susceptibility results once available, as recommended by the British Thoracic Society 3, 4
  • If vancomycin MIC is <2 μg/mL, continue vancomycin based on clinical response, according to the Infectious Diseases Society of America 2
  • Alternative agents include linezolid 600 mg IV/PO twice daily or daptomycin 6 mg/kg IV once daily, as suggested by the Infectious Diseases Society of America 1, 2

Urgent Drainage Procedures

  • The British Thoracic Society recommends inserting bilateral small-bore chest drains under ultrasound guidance within 24 hours of diagnosis 3, 4
  • Administer intrapleural urokinase 40,000 units in 40 mL 0.9% saline twice daily for 3 days to facilitate drainage and break down loculations, as recommended by the British Thoracic Society 5, 6

Critical Surgical Timing

  • Obtain early discussion with a thoracic surgeon if the patient fails to respond to chest tube drainage, antibiotics, and fibrinolytics within 48-72 hours, as recommended by the Society of Thoracic Surgeons 5
  • Specific indications for surgical intervention include persisting sepsis after 5-7 days of appropriate drainage and antibiotics, as suggested by the British Thoracic Society 3, 4, 7

Duration of Antibiotic Therapy

  • The Infectious Diseases Society of America recommends continuing IV antibiotics for a minimum of 2-4 weeks, with total duration of 4-6 weeks for complicated cases depending on clinical response and adequacy of drainage 1, 3, 4
  • For empyema complicated by bacteremia, treat as complicated bacteremia with 4-6 weeks of therapy, as recommended by the Infectious Diseases Society of America 1

Important Caveats and Pitfalls

  • Avoid aminoglycosides, as they have poor pleural space penetration and are inactive in acidic pleural fluid, as recommended by the British Thoracic Society 3, 4
  • Do not administer antibiotics directly into the pleural space—IV administration provides adequate pleural penetration, according to the British Thoracic Society 3, 4

Supportive Care Measures

  • Ensure adequate nutritional support from the outset, as poor nutrition is associated with worse outcomes, as recommended by the British Thoracic Society 7
  • Do not perform chest physiotherapy—it provides no benefit in empyema, as suggested by the British Thoracic Society 5, 6, 8

Monitoring and Follow-Up

  • Obtain blood cultures 2-4 days after initial cultures to document clearance if bacteremia is present, as recommended by the Infectious Diseases Society of America 1
  • Continue follow-up until complete clinical recovery and chest radiograph returns to near normal, which may take weeks to months, as recommended by the British Thoracic Society 5, 6

Step-Down Antibiotics in Empyema

Timing of Step-Down Therapy

  • Switch to oral antibiotics once the patient demonstrates clinical improvement: resolution of fever, decreasing white blood cell count, and effective pleural drainage 9
  • Assessment of treatment effectiveness should occur 5-8 days after starting chest tube drainage and antibiotics, at which point step-down can be considered if sepsis is resolving 10, 11

Spectrum Coverage During Step-Down

  • Community-acquired empyema requires coverage of Pneumococcus, Staphylococcus aureus, Haemophilus influenzae, and anaerobes 9
  • Appropriate oral step-down regimens include combinations that maintain this spectrum, such as amoxicillin-clavulanate or clindamycin 9

Practical Step-Down Algorithm

  • Confirm adequate source control: chest tube draining effectively, no persistent loculations on imaging 10, 11
  • Select oral agent based on culture results when available, or empiric coverage maintaining anti-anaerobic activity 9

Critical Pitfalls to Avoid

  • Never discontinue anti-anaerobic coverage prematurely – anaerobes are frequently co-isolated and their inadequate treatment increases failure rates 9
  • Avoid aminoglycosides entirely as they have poor pleural space penetration and are inactive in acidic pleural fluid 9

Special Considerations

  • Ensure adequate nutritional support throughout treatment, as poor nutrition is associated with worse outcomes and slower recovery from the catabolic effects of chronic infection 10, 11